Cyprus Inflation Eases Slightly To 2.5% In January

by THEFUTURE.TEAM

February 7, 2025

Inflation in Cyprus stood at 2.5% in January, down marginally from 2.6% in December, according to the Cyprus Statistical Service (Cystat). The Consumer Price Index (CPI) dropped by 1.58 points to 116.73, reflecting a slowdown in price growth.

Agricultural Goods saw the most volatility, rising 10% year-on-year but declining 6.1% from December. Food and Non-Alcoholic Beverages increased by 4.8% annually, while Restaurants and Hotels rose by 4.1%. Clothing and Footwear recorded the steepest monthly drop, falling 13%.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The biggest contributors to annual inflation were Food and Non-Alcoholic Beverages (+1.07) and Transport (+0.56), while Clothing and Footwear (-0.18) exerted downward pressure. Month-on-month, Clothing and Footwear (-1.00) had the most significant deflationary effect.

Catering Services (+0.48), Fresh Vegetables (+0.36), and Meat (+0.24) were key drivers of price increases, while Clothing Items (-0.81) pulled inflation down. Petroleum Products had the largest positive monthly impact (+0.15), while Clothing Items saw the biggest decline (-0.71).

The Future Forbes Realty Global Properties

Anthropic Acquires Coefficient Bio In $400 Million Stock Deal

by THEFUTURE.TEAM

April 6, 2026

Anthropic acquired biotech AI startup Coefficient Bio in a deal valued at approximately $400 million in stock, according to people familiar with the matter. Sources confirmed the transaction, although detailed financial terms were not publicly disclosed.

Deepening Forays Into Healthcare And Life Sciences

The acquisition follows Anthropic’s earlier launch of Claude for Life Sciences, a tool designed to support scientific research and drug discovery. The deal expands the company’s activity in healthcare and biotechnology. Anthropic is increasing its focus on applying AI models to scientific workflows, including data analysis and experimental design. Expansion into life sciences reflects broader industry trends.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Transforming Computational Drug Discovery

Coefficient Bio was founded eight months ago by Samuel Stanton and Nathan C. Frey, both former researchers at Genentech’s Prescient Design group. The company focused on applying AI to drug discovery and biological research processes. Its technology aims to improve efficiency in identifying drug candidates and analyzing biological data. Early-stage development reflects growing interest in AI-driven research tools.

Strategic Talent And Expertise Integration

Around 10 employees from Coefficient Bio will join Anthropic following the acquisition, strengthening its health and life sciences team. The group will contribute to the development of AI models for scientific and medical applications. Access to specialized talent supports the expansion of capabilities in drug discovery and biological research.

Industry Context And Outlook

Investment in AI for drug discovery has increased as companies seek to reduce development timelines and costs. Large technology firms and startups are expanding activity in this area. Further developments will depend on how effectively Anthropic integrates the team and advances its life sciences strategy.

Breaking news